7-75987282-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_031925.3(TMEM120A):c.922C>A(p.Leu308Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000582 in 1,597,078 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 7/8 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031925.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM120A | NM_031925.3 | c.922C>A | p.Leu308Ile | missense_variant | 12/12 | ENST00000493111.7 | NP_114131.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM120A | ENST00000493111.7 | c.922C>A | p.Leu308Ile | missense_variant | 12/12 | 1 | NM_031925.3 | ENSP00000473983.1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152264Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000364 AC: 8AN: 219904Hom.: 0 AF XY: 0.0000503 AC XY: 6AN XY: 119332
GnomAD4 exome AF: 0.0000581 AC: 84AN: 1444696Hom.: 3 Cov.: 33 AF XY: 0.0000600 AC XY: 43AN XY: 717250
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152382Hom.: 0 Cov.: 34 AF XY: 0.0000671 AC XY: 5AN XY: 74526
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2023 | The c.922C>A (p.L308I) alteration is located in exon 12 (coding exon 12) of the TMEM120A gene. This alteration results from a C to A substitution at nucleotide position 922, causing the leucine (L) at amino acid position 308 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at